Uniform suspension of the clustered triamcinolone acetonide particle

Masahiko Sugimoto, Mineo Kondo, Masayuki Horiguchi

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Purpose. MaQaid (MaQ) is a new triamcinolone acetonide commercialised in Japan to visualize the vitreous. Because MaQ is preservative-free, it has a lower risk of ocular toxicities. However, since MaQ is only available as a powder, it needs suspenssion. Suspension does not always result uniformally, which causes poor visibility. This study reports a new MaQ suspension for better visibility. Methods. After medium addition to a MaQ vial, various methods were used. These included the use of (1) vortex mixer, (2) two syringes and a three-way stopcock, and (3) ultrasonic washer. We calculated suspended MaQ concentration (n = 5). To evaluate the reproducibility, we estimated the coefficient of variance (CV, n = 3). We used this MaQ for pig eyes, and vitreous visualization was simulated. Subsequently, we used this MaQ suspension for humans. Results. MaQ suspensions were sucessfull, and the concentrations of single particles increased significantly (P < 0.01). The CV was 36.1% for the routine method and 9.03% ffor the new method. Administration of a suspended MaQ made it possible to clearly visualize the vitreous in both pig and human eyes. Conclusions. We devised new techniques for uniformal MaQ suspension. These new methods can compensate for the MaQ disadvantages and ensure a safety surgery.

Original languageEnglish
Article number315658
JournalJournal of Ophthalmology
Publication statusPublished - 2013

All Science Journal Classification (ASJC) codes

  • Ophthalmology


Dive into the research topics of 'Uniform suspension of the clustered triamcinolone acetonide particle'. Together they form a unique fingerprint.

Cite this